Projects

CD163 - TRAIN project

TRAIN subprojects

 

Macrophage markers in diabetes

Macrophage markers including soluble CD163 as predictors for development of type 2 diabetes and its complication. Cohorte studies on prediabetic and type 2 diabetic individuals

 

Contact:

Annelli Sandbæk (MD, PhD) - e-mail: annelli.sandbaek@alm.au.dk

Pia Deichgræber (MD) - e-mail: p.deichgraeber@alm.au.dk

 

Macrophage markers in obesity and liver disease

- Intervention study

- Prediction study

- Obesity study

- Biomarker study

Contact:

Holger Jon Møller (MD, PhD) - e-mail: holgmoel@rm.dk

Sidsel Rødgaard-Hansen (MD) - e-mail: sidsroed@rm.dk

 

Inflammatory effects on glucose homeostasis

- Influence of obesity, weight loss, and diet on low grade inflammation with particular focus on the macrophage marker, soluble-CD163 - a new predictor of diabetes and cardiovascular diseases. Can s-CD163 discriminate between healthy and unhealthy obese individuals

 

Contact:

Bjørn Richelsen (MD, PhD) - e-mail: bjoerich@rm.dk

Karen Fjeldborg (MD) - e-mail: fjeldkaren@yahoo.dk

 

Macrophage activation and liver disease

- Histology study

- Childhood obesity study

 

Contact:

Henning Grønbæk (MD, PhD) - e-mail: henngroe@rm.dk

Konstantin Kazankov (MD) - e-mail: konka@dadlnet.dk

 

Medical Targeting of Kupffer Cells

Contact:

Holger Jon Møller (MD, PhD) - e-mail: holgmoel@rm.dk

Søren Kragh Moestrup (MD, PhD) - e-mail: sm@biokemi.au.dk